focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraft Polymer Regulatory News (GPL)

Share Price Information for Graft Polymer (GPL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.145
Bid: 0.14
Ask: 0.15
Change: 0.00 (0.00%)
Spread: 0.01 (7.143%)
Open: 0.145
High: 0.145
Low: 0.145
Prev. Close: 0.145
GPL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Chairman & Directorate Change & Financial Update

15 Mar 2024 07:00

RNS Number : 9380G
Graft Polymer (UK) PLC
15 March 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION HEREIN (THE "ANNOUNCEMENT") IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, TRANSMISSION, DISTRIBUTION OR FORWARDING DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, RUSSIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, TRANSMISSION, RELEASE, DISTRIBUTION OR FORWARDING WOULD BE UNLAWFUL.?THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY. IN PARTICULAR, PERSONS RECEIVING THIS ANNOUNCEMENT SHOULD READ AND UNDERSTAND THE INFORMATION PROVIDED IN THE "IMPORTANT NOTICES" SECTION OF THIS ANNOUNCEMENT. 

? 

FURTHER, THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE SHARES IN GRAFT POLYMER (UK) PLC IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. 

?? 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.  

 

15 March 2024

Graft Polymer (UK) Plc 

(the "Company") 

New Chairman appointment, resignation of two directors, loan facility agreement, financial update and appointment of joint broker  

? 

Board changes

 

Graft Polymer Plc (LSE:GPL) announces the resignations of two directors of the Company these being Roby Zomer, the Non-Executive Chairman of the Company, and Alex Brooks a Non-Executive Director. Nicholas Nelson has today been appointed as a director of the Company replacing Mr Zomer as Non-Executive Chairman of the Company with immediate effect. Mr Zomer will remain as a consultant to the Company.

 

Nicholas Nelson commenced his career in the City in 1985 in stockbroking before moving into the financial PR industry in 1999. He has previously served as a director on the boards of seven small cap quoted companies, both in executive and non-executive positions.

 

New loan facility

 

The changes to the board follow the provision of a £100,000 working capital loan facility to the Company by Mr Nelson and another private individual (the "Loan Facility"). The Loan Facility is intended to be drawn down in full against expenses incurred by the Company as they arise, and it attracts an interest rate of 10% per month. Although the loan is technically repayable on demand, together with accumulated interest, it is mutually agreed in writing to convert all or any part of the outstanding balance of the Loan (including interest) in the form of new ordinary shares issued by the Company at a price and time agreed between the lenders and the Company. 

 

Financial update

Over recent months the Company has experienced very difficult trading conditions due to the conflicts in the Middle East, Ukraine and the Red Sea. As a consequence, the Company's cash position has become extremely constrained thus necessitating the need for the Company to enter into the Loan Facility. The Loan Facility will allow the Company to continue to trade and will permit the Company's audit for the year ended 31 December 2023 to be completed.

 

Appointment of joint broker

 

The Company announces the appointment of Allenby Capital as joint broker to the Company. 

 

Roby Zomer, outgoing Chairman, commented: 

 

"The shocking conflicts taking place in the Middle East, Ukraine and the Red Sea have had a major impact on the Company and conspired to undermine our business development plans. With the severe constraints on our ability to trade, our financial position has become parlous, forcing the Company to undertake an urgent review of its future direction.

 

"We thank Nicholas and the other lender for providing us with interim working capital. Nicholas's priority as the incoming Chairman is to establish sources of additional funding whilst working with the board to consider the best future for Graft Polymer." 

 

Enquiries:  

 

Graft Polymer (UK) Plc 

Nicholas Nelson, Non-Executive Chairman 

nelson@nexfin.org.uk 

 

Yifat Steuer, CFO and Executive Director 

 

 

Allenby Capital (Joint broker)

Nick Naylor / Liz Kirchner (Corporate Finance) 

 

Guy McDougall (Sales) 

?+44 (0) 20 3328 5656 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABLGDXRXBDGSS
12
Date   Source Headline
9th May 20247:00 amRNSUpdate on recent developments
7th May 20247:00 amRNSGrant of Haemostatic Hydrogel Patent
3rd May 20247:00 amRNSDivestment of Graft Polymer d.o.o – Slo facility
2nd May 20247:00 amRNSReplacement of Chief Executive Officer
30th Apr 20245:05 pmRNSAnnual Financial Report
23rd Apr 20244:17 pmRNSLoan facility update
15th Mar 20247:00 amRNSChairman & Directorate Change & Financial Update
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSGM Statement
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSGM Notice 8th January 2024
22nd Dec 20237:00 amRNSPlacing of New Ordinary Shares
9th Oct 20237:00 amRNSPivotal Agreement within European Consortium
27th Sep 20237:02 amRNSUpdated Investor Presentation
27th Sep 20237:00 amRNSInterim Financial Results
11th Sep 20237:00 amRNSR&D Agreement with Slovenian Faculty
4th Sep 20237:00 amRNSR&D and supply agreement with FORPET BALTIC
30th Aug 20237:00 amRNSR&D Supply Agreement Signed
23rd Aug 20237:00 amRNSGraft Bio signs manufacturing services agreement
27th Jul 202311:54 amRNSResult of AGM
26th Jul 20237:00 amRNSDistribution agreement with US Inter-Technologies
6th Jul 20237:00 amRNSNew R&D and Supply Agreement with Gabriel Chemie
5th Jul 20237:00 amRNSOperational Update
4th Jul 20237:00 amRNSAGM Notice
16th May 20232:08 pmRNSDirector Share Purchase
27th Apr 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSGraftBio - MGC Pharma Update
20th Mar 20237:00 amRNSCorporate Presentation
9th Feb 20237:00 amRNSUpdate: New Product Lines & Facility Expansion
30th Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSNew Corporate Presentation
18th Aug 202210:00 amRNSFirst Commercial Purchase Order for GraftBio
28th Jul 202212:30 pmRNSResult of AGM
4th Jul 20224:50 pmRNSNotice of AGM
29th Jun 20227:00 amRNSFinal Results
20th Jun 20227:00 amRNSOperational Update
17th Jun 20227:00 amRNSGraftBio IP – MGC Pharma Update
18th May 20227:00 amRNSDirector Share Purchase
12th May 20227:00 amRNSHACCP Certificate Enabling Access to B2C Market
22nd Apr 20227:17 amRNSGrant of patents
7th Apr 20227:00 amRNSPre-payment for equipment
6th Apr 202211:50 amRNSDirector/PDMR Shareholding
21st Feb 20227:00 amRNSUpdate on Operations
15th Feb 20227:00 amRNSChange of Year End
25th Jan 20227:00 amRNSBusiness Update
11th Jan 20227:00 amRNSInvestor Presentation
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.